A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Clinical trial NCT05716100 · RECRUITING
Trial details
- NCT number
- NCT05716100
- Sponsor
- Xenon Pharmaceuticals Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-09
- Primary completion
- 2026-10-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.